Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CIMOTCMKTS:GTAXNYSE:MACCOTCMKTS:PAIR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCIMChimera Investment$14.10-1.7%$13.41$9.85▼$16.89$1.16B1.74569,574 shs464,771 shsGTAX(GTAX)$0.00$0.00▼$0.00N/AN/AN/AN/AMACCMission Advancement$10.06$10.05$9.63▼$10.09$433.84M0.04130,313 shs101 shsPAIR(PAIR)$0.00$0.00▼$0.00N/AN/AN/AN/AOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCIMChimera Investment0.00%+1.35%+4.74%+30.58%+9.58%MACCMission Advancement0.00%0.00%0.00%0.00%0.00%PAIR(PAIR)0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCIMChimera Investment3.5455 of 5 stars1.23.01.73.23.10.81.9GTAX(GTAX)N/AN/AN/AN/AN/AN/AN/AN/AMACCMission AdvancementN/AN/AN/AN/AN/AN/AN/AN/APAIR(PAIR)N/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCIMChimera Investment 2.33Hold$15.509.93% UpsideGTAX(GTAX) 0.00N/AN/AN/AMACCMission Advancement 0.00N/AN/AN/APAIR(PAIR) 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CIM, GTAX, MACC, and PAIR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/14/2025CIMChimera InvestmentUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy$11.50 ➝ $15.00(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCIMChimera Investment$760.95M1.50$2.75 per share5.13$31.23 per share0.45GTAX(GTAX)N/AN/AN/AN/AN/AN/AMACCMission AdvancementN/AN/A$1.28 per share7.84($2.56) per shareN/APAIR(PAIR)N/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCIMChimera Investment$176.07M$1.509.40∞N/A25.12%7.25%1.44%8/6/2025 (Estimated)GTAX(GTAX)N/AN/A0.00N/AN/AN/AN/AN/AN/AMACCMission Advancement$11.07MN/A0.00∞N/AN/A-54.76%2.71%N/APAIR(PAIR)N/AN/A0.00N/AN/AN/AN/AN/AN/ALatest CIM, GTAX, MACC, and PAIR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025CIMChimera Investment$0.38$0.41+$0.03$1.77$72.07 million$69.22 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCIMChimera Investment$1.4810.50%N/A98.67%1 YearsGTAX(GTAX)N/AN/AN/AN/AN/AMACCMission AdvancementN/AN/AN/AN/AN/APAIR(PAIR)N/AN/AN/AN/AN/ALatest CIM, GTAX, MACC, and PAIR DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/11/2025CIMChimera Investmentquarterly$0.3710.64%6/30/20256/30/20257/31/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCIMChimera Investment3.933.703.70GTAX(GTAX)N/AN/AN/AMACCMission AdvancementN/A0.150.15PAIR(PAIR)N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCIMChimera Investment48.44%GTAX(GTAX)N/AMACCMission Advancement66.40%PAIR(PAIR)N/AInsider OwnershipCompanyInsider OwnershipCIMChimera Investment0.91%GTAX(GTAX)N/AMACCMission Advancement19.70%PAIR(PAIR)N/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCIMChimera Investment4080.97 million80.23 millionOptionableGTAX(GTAX)N/AN/AN/ANot OptionableMACCMission Advancement343.13 million34.63 millionNot OptionablePAIR(PAIR)N/AN/AN/ANot OptionableCIM, GTAX, MACC, and PAIR HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCIM, GTAX, MACC, and PAIR Company DescriptionsChimera Investment NYSE:CIM$14.10 -0.24 (-1.67%) Closing price 03:59 PM EasternExtended Trading$14.16 +0.06 (+0.43%) As of 07:26 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Chimera Investment Corporation operates as a real estate investment trust (REIT) in the United States. The company, through its subsidiaries, invests in a portfolio of mortgage assets, including residential mortgage loans, agency residential mortgage-backed securities, non-agency residential mortgage-backed securities, agency mortgage-backed securities secured by pools of commercial mortgage loans, business purpose and investor loans, and other real estate related securities. It invests in investment grade, non-investment grade, and non-rated classes. The company qualifies as a real estate investment trust (REIT) for federal income tax purposes. As a REIT, it intends to distribute at least 90% of its taxable income as dividends to shareholders. Chimera Investment Corporation was incorporated in 2007 and is headquartered in New York, New York.(GTAX) OTCMKTS:GTAXGilman Ciocia, Inc. provides federal, state and local taxes preparation services to individuals, predominantly in the middle and upper income tax brackets, accounting services to small and midsize companies and financial planning services, including securities brokerage, investment management services, insurance and financing services. As of June 30, 2012, the Company had 27 offices operating in three states (New York, New Jersey, and Florida). The Company also provides financial planning services through approximately 33 independently owned and operated offices in 10 states. The Company's financial planning clients are introduced to the Company through the Company's tax return preparation services, accounting services and educational workshops. In October 2013, National Holdings Corporation announced that it has the completed the merger with Gilman Ciocia, Inc.Mission Advancement NYSE:MACCMission Advancement Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Mission Advancement Corp. was incorporated in 2020 and is based in Phoenix, Arizona.(PAIR) OTCMKTS:PAIR More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CoreWeave's $9 Billion Power Play for Core Scientific Micron Insiders Sell But Investors Should Buy, Buy, Buy Could Dutch Bros Dethrone Starbucks? Why Investors Are Perking Up ExxonMobil: Limited Risk and Lots of Reward With This Oil Play D-Wave Is Rising Again Despite Dilution—What’s the Deal? Datadog Joins S&P 500, Triggering a New Wave of Upside MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
